ライフサイエンスコーパス: perfluorocarbon

1 h standardized volumes of either room air or perfluorocarbon.

2 safely with minute quantities of intravenous perfluorocarbon.

3 kes each for heliox (70:30 mixture), NO, and perfluorocarbon.

4 ttraction for the aqueous interface, such as perfluorocarbons.

5 quid ventilation with temperature-controlled perfluorocarbons.

6 hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbons.

7 tion of CO2 and 0.64-0.76 mL.min(-1) loss of perfluorocarbon across the fibers.

8 This study suggests that different perfluorocarbons affect adhesions differently.

9 were injected with a commercially available perfluorocarbon and were examined in vivo with an 11.7-T

10 Anions derived from perfluorocarbons appear to be directly applicable to mix

11 Intravenously administered perfluorocarbons are taken up by infiltrating inflammato

12 There is considerable interest in the use of perfluorocarbons as oxygen carriers in clinical settings

13 s ventilation (control, n=9) or to institute perfluorocarbon-associated gas exchange (n=9) by instill

14 ants of gas exchange would be similar during perfluorocarbon-associated gas exchange and conventional

15 dult sheep with acid aspiration lung injury, perfluorocarbon-associated gas exchange at an FIO2 of <1

16 We hypothesized that a) perfluorocarbon-associated gas exchange could be accompl

17 lation; c)in large animals with lung injury, perfluorocarbon-associated gas exchange could be used to

18 er, survival was significantly higher in the perfluorocarbon-associated gas exchange group with eight

19 osis (p<.05), while pH did not change in the perfluorocarbon-associated gas exchange group.

20 essure directly influence oxygenation during perfluorocarbon-associated gas exchange in large animals

21 ventilation determined CO2 clearance during perfluorocarbon-associated gas exchange in normal sheep.

22 After acid aspiration lung injury, perfluorocarbon-associated gas exchange increased PaO2 a

23 Five normal ewes (61.0 +/- 4.0 kg) underwent perfluorocarbon-associated gas exchange to ascertain the

24 Within 15 mins of initiating perfluorocarbon-associated gas exchange, oxygenation inc

25 nfluenced oxygenation in normal sheep during perfluorocarbon-associated gas exchange.

26 uld be supported with an FIO2 of <1.0 during perfluorocarbon-associated gas exchange.

27 cs were not influenced by the institution of perfluorocarbon-associated gas exchange.

28 Here, we describe the formulation of perfluorocarbon-based nanoemulsions with improved sensit

29 iguous understanding of the oleophobicity of perfluorocarbon chain in PFOS, and it is helpful for the

30 the order of PFSAs > PFCAs > PFPAs of equal perfluorocarbon chain length and was dependent on the ch

31 Perfluorocarbon chain of perfluorooctane sulfonate (PFOS

32 The perfluorocarbon chain repels hydrophobic compounds and i

33 ces of air bubbles with the hydro-oleophobic perfluorocarbon chain stretching into air bubbles and th

34 In 5 additional animals, perfluorocarbon combined with FITC (fluorescein isothioc

35 10 to 20 Hz) after intravenous injections of perfluorocarbon containing microbubbles has the potentia

36 ivo accumulation of semipermeable 200-300 nm perfluorocarbon core nanoparticles (PFC-NP) in ApoE null

37 c resonance spectroscopy of the nanoparticle perfluorocarbon core, yielding a quantitative estimate o

38 NO at 25 ppm and perfluorocarbon did not interfere with the accuracy of a

39 The presence of perfluorocarbon did not interfere with the MDA assay whe

40 The perfluorocarbon dose was repeated daily for a total of 3

41 (19)F MRS of a perfluorocarbon droplet provides an accurate measure of

42 re labeled by intravenous injection of (19)F-perfluorocarbon emulsion 1 day after MI.

43 e measured experimentally by incorporating a perfluorocarbon emulsion in the beads and acquiring (19)

44 The agent is a biotinylated, lipid-coated, perfluorocarbon emulsion that has low inherent echogenic

45 Perfluorocarbon emulsions (PFCEs) have high O2-dissolvin

46 Perfluorocarbon emulsions activate complement and cause

47 ed on either hemoglobin (animal or human) or perfluorocarbon emulsions are in advanced stages of clin

48 ulfate for detection by X-ray modalities; or perfluorocarbon emulsions for multimodal detection by (1

49 ions of modified cell-free hemoglobin and of perfluorocarbon emulsions have demonstrated significant

50 Safe doses of perfluorocarbon emulsions have very limited oxygen-carry

51 velopment are based on cell-free hemoglobin, perfluorocarbon emulsions, or liposome-encapsulated hemo

52 o avidin and then to biotinylated or control perfluorocarbon emulsions.

53 approach with intravenous administration of perfluorocarbon-exposed sonicated dextrose albumin (PESD

54 We have shown previously that perfluorocarbon-exposed sonicated dextrose albumin (PESD

55 ntermittent harmonic imaging and intravenous perfluorocarbon-exposed sonicated dextrose albumin contr

56 ial contrast after intravenous injections of perfluorocarbon-exposed sonicated dextrose albumin micro

57 nd contrast can be produced from intravenous perfluorocarbon-exposed sonicated dextrose albumin, and

58 acterial adhesion and viability after liquid perfluorocarbon exposure and to assess bacterial recover

59 f the potential implications of intrauterine perfluorocarbon exposure during critical periods of feta

60 Continuous perfluorocarbon exposure with this method is reproducibl

61 ts with a previous MI using bolus doses of a perfluorocarbon-filled contrast agent (NC100100).

62 Gas ventilation of the perfluorocarbon-filled lungs (partial liquid ventilation

63 Lipid-shell perfluorocarbon-filled MBs, targeted to VEGFR2 via anti-

64 integrin, or both antibodies to the shell of perfluorocarbon-filled MBs.

65 attaching Knottin(Integrin) to the shell of perfluorocarbon-filled microbubbles (MB-Knottin(Integrin

66 PCCAs are lipid-coated, perfluorocarbon-filled particles formulated as nanoscale

67 diography by using an intravenous bolus of a perfluorocarbon-filled, albumin-(Optison: n = 98) or lip

68 ese requirements but have high resistance to perfluorocarbon flow and high priming volume.

69 image nanoscale lipid and polymer-stabilized perfluorocarbon gas bubbles before and after their destr

70 MBs were prepared by emulsification of perfluorocarbon gas in phospholipids and decorated with

71 was performed using intravenous injection of perfluorocarbon gas-containing microbubbles during two-d

72 duced dissipation of nanobubble encapsulated perfluorocarbon gas.

73 microspheres (2-micron diameter) filled with perfluorocarbon gas.

74 hers approximately sulfur/carbon compounds > perfluorocarbons > perfluoroolefins > carbon/nitrogen co

75 itive emulsion droplets composed of a liquid perfluorocarbon have the potential to be a highly effici

76 cence recovery after photobleaching, using a perfluorocarbon immersion lens and confocal fluorescence

77 and flow cytometry confirmed the presence of perfluorocarbon in macrophages, dendritic cells, and gra

78 ultrasonography (US) after the inclusion of perfluorocarbon in the capsules.

79 nt for Xe NMR based on surfactant-stabilized perfluorocarbon-in-water nanoemulsions has been produced

80 adiolabeled Escherichia coli were exposed to perfluorocarbon, incubated against artificial biosurface

81 In the Liquid Warm group, perfluorocarbon inhalation did not alter infarct size co

82 compared with control animals, intratracheal perfluorocarbon instillation resulted in significant imp

83 Oxygen delivery improved with perfluorocarbon instillation, but this improvement was n

84 y exchanges between aqueous solution and the perfluorocarbon interior of the droplets, which are spec

85 The present study investigated variation in perfluorocarbon levels of 9952 women of childbearing age

86 y isolating small-sized (diameter <6 microm) perfluorocarbon liquid droplets from polydisperse drople

87 The intratracheal administration of a perfluorocarbon liquid during continuous positive-pressu

88 tion (PLV) with two different dosages of the perfluorocarbon LiquiVent (perflubron) on pulmonary vasc

89 Estimated in vivo perfluorocarbon loss from the device was 1.2 mL.min(-1).

90 Perfluorocarbon may be safely administered into the lung

91 tly the intravenous (i.v.) administration of perfluorocarbon microbubbles has been shown to enhance o

92 After incubation with albumin-coated perfluorocarbon microbubbles, an adenovirus encoding a r

93 studied as candidate blood substitutes: the perfluorocarbons, modified hemoglobins, and liposome-enc

94 Our agent consists of liquid perfluorocarbon nanodroplets with encapsulated plasmonic

95 pha2-antiplasmin peptide (alpha2AP)-targeted perfluorocarbon nanoemulsions (PFCs) as contrast agent,

96 de)-co-polylactide micelles or corresponding perfluorocarbon nanoemulsions.

97 fluorofluorophores by preparing fluorescent perfluorocarbon nanoemulsions.

98 his strategy by generating a VCAM-1-targeted perfluorocarbon nanoparticle for in vivo targeting in at

99 melittin into the outer lipid monolayer of a perfluorocarbon nanoparticle.

100 particles for stem-cell tracking, multimodal perfluorocarbon nanoparticles for visualization of angio

101 low priming volume to minimize the amount of perfluorocarbon needed.

102 r intravenous injection of 2x200 microL of a perfluorocarbon on day 19 and 20 (n=9) after immunizatio

103 ch holds a thin liquid film of medical-grade perfluorocarbon on the surface.

104 as low as 100 fM, corresponding to <1 muL of perfluorocarbon per liter of solution.

105 vIII targeting transgene were labeled with a perfluorocarbon (PFC) emulsion ex vivo and infused into

106 lessons learned from initial attempts using perfluorocarbon (PFC) emulsions and acellular hemoglobin

107 Perfluorocarbon (PFC) emulsions were injected intravenou

108 The administration of a perfluorocarbon (PFC) liquid, such as perflubron, during

109 port the synthesis and formulation of unique perfluorocarbon (PFC) nanoemulsions enabling intracellul

110 cells labeled with different types of liquid perfluorocarbon (PFC) nanoparticles produces unique and

111 The trend for the perfluorocarbon (PFC) radicals is quite different.

112 Perfluorocarbons (PFC) are hydrocarbons in which all or

113 Perfluorocarbons (PFCs) are promising blood substitutes

114 stabilization of low-boiling point (low-bp) perfluorocarbons (PFCs) at physiological temperatures by

115 Perfluorocarbons (PFCs) hold great promise for biomedica

116 d/or climate forcing, from the very volatile perfluorocarbons (PFCs, e.g., CF(4) and CH(3)CF(3)) and

117 to examine the requirements for designing a perfluorocarbon (PFT) monitoring network and tracer tagg

118 tectors: (1) sample confinement using liquid perfluorocarbon plugs to increase the observe factor, (2

119 er, if the sample is bracketed by two liquid perfluorocarbon plugs, the observe factor can be increas

120 Liquid ventilation with perfluorocarbon previously has not been reported in pedi

121 Using a perfluorocarbon purification handle, we were able to pur

122 including R = alkyl, hydroxy, phenyl, ester, perfluorocarbon) reported here derives from a single, re

123 ough fluorophilic interactions of a blend of perfluorocarbon (RF) end-functionalized polystyrene and

124 results indicate that at 25 degrees C in the perfluorocarbon-rich phase, both solvent components inte

125 Perfluorocarbons similarly reduce the need for allogenei

126 ets are injected into a low refractive index perfluorocarbon so that they can be optically trapped.

127 itives in the aqueous phase and carboxylated perfluorocarbon surfactants in the oil phase.

128 the quantitative measurement of atmospheric perfluorocarbon trace species at the sub part per quadri

129 The perfluorocarbon-treated animals had a significantly lowe

130 Upon pulsed laser irradiation, liquid perfluorocarbon undergoes a liquid-to-gas phase transiti

131 After 2 to 9 days on ECLS, perfluorocarbon was administered into the trachea until

132 No leakage of perfluorocarbon was noted in the new silicone fiber gas

133 Perfluorocarbon was then instilled via the endotracheal

134 in which the airspace was filled with inert perfluorocarbon, was reduced more than 10-fold in AQP1 (

135 ometer using 25 ppm of NO, 50 ppm of NO, and perfluorocarbon were within +0.25%, -0.7%, and +0.4%, re

136 lently tethered, flexible molecular layer of perfluorocarbon, which holds a thin liquid film of medic